⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1713762 | 0.96 | — | — | |
| Phosphonic Acid SCHEMBL11026022 | 0.87 | KDM5B (0.40) | — | |
| SCHEMBL2239024 | 0.79 | — | — | |
| SCHEMBL27674290 | 0.74 | — | — | |
| SCHEMBL27793358 | 0.74 | — | — | |
| SCHEMBL23829712 | 0.74 | KDM5B (0.56) | — | |
| SCHEMBL16442466 | 0.74 | KDM5B (0.33) | — | |
| SCHEMBL12120864 | 0.74 | KDM5B (0.33) | — | |
| SCHEMBL5068632 | 0.74 | — | — | |
| SCHEMBL7621254 | 0.72 | MMP2 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082897-A | Preparation method for electrochemically synthesizing N-substituted pyridine-2-formamide | 九洲药业(杭州)有限公司 | 2025-06-03 | — | — | CN | claimed |
| EP-2090571-B1 | Pyrimidine derivates, medicaments comprising them, their use and process of their preparation | BOEHRINGER INGELHEIM PHARMA (DE) | 2012-05-16 | — | — | EP | claimed |
| EP-2168957-B1 | Alkyl-substituted tetrahydropyranes as aromatic materials | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20090099157-A1 | TETRAHYDRO-PYRAZOLO-PYRIDINE THIOETHER MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. | 2009-04-16 | — | — | US | claimed |
| WO-2008100621-A2 | TETRAHYDRO-PYRAZOLO-PYRIDINE THIOETHER MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2008-08-21 | — | — | WO | claimed |
| US-6114532-A | ANTICOAGULANT | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2000-09-05 | — | — | US | claimed |
| EP-0271468-A2 | Gallium complexes and solvent extraction of gallium | Monsanto Company (US) | 1988-06-15 | — | — | EP | claimed |
| US-4741887-A | Gallium complexes and solvent extraction of gallium | MONSANTO COMPANY (US) | 1988-05-03 | — | — | US | claimed |
| CN-122036800-A | Oxamide compound and application thereof in medicine | 杭州百新生物医药科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132109-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY | NOVARTIS PHARMA AG (CH) | 2026-05-14 | — | — | US | disclosed |
| US-12503436-B2 | Compounds and compositions for treating conditions associated with STING activity | NOVARTIS PHARMA AG (CH) | 2025-12-23 | — | — | US | disclosed |
| US-12370158-B2 | Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation | OMEICOS THERAPEUTICS GMBH (DE) | 2025-07-29 | — | — | US | disclosed |
| US-12319640-B2 | Cyclic diones as herbicidal compounds | SYNGENTA CROP PROTECTION AG (CH) | 2025-06-03 | — | — | US | disclosed |
| CN-120082897-A | Preparation method for electrochemically synthesizing N-substituted pyridine-2-formamide | 九洲药业(杭州)有限公司 | 2025-06-03 | — | — | CN | disclosed |
| EP-0781774-A2 | Prolactin production inhibitory agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-07-02 | — | — | EP | disclosed |
| WO-1997014697-A1 | THIENOPYRIDINE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE ANTAGONISTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-24 | — | — | WO | disclosed |
| CN-1136311-A | Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action | MERRELL DOW PHARMA (US) | 1996-11-20 | — | — | CN | disclosed |
| CN-1126204-A | Intermediates for pyrazolyl acetic acid derivatives | SANDOZ LTD (CH) | 1996-07-10 | — | — | CN | disclosed |
| WO-1993015044-A1 | N-BENZYLOXAMIC ACID, OXAMATE, AND OXAMIDE DERIVATIVES AND THEIR USE AS TNF AND PDE IV INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1993-08-05 | — | — | WO | disclosed |
| US-4684751-A | HYDRATION OF NITRILES AND ALKENES, PHASE TRANSFER AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1987-08-04 | — | — | US | disclosed |